The Canadian Veterinary Association has publicly raised alarms on two pressures now straining practices across the country: shortages of veterinary medicines and mounting burnout among clinic staff.

The association's warning, reported by CBC, names the dual problem directly. Practices face difficulty obtaining needed medicines at the same time that the people who deliver care — veterinarians, technicians and support staff — are working under sustained, escalating strain.

For practicing veterinarians, a medicine shortage is not an administrative inconvenience. It is a clinical problem that surfaces at the exam table. When a drug becomes unavailable, clinicians must identify alternatives, adjust dosing, confirm that substitutes are appropriate for the species in front of them, and communicate changes to clients who may face higher costs or different treatment expectations. Shortages also complicate anesthesia protocols, antimicrobial selection and chronic-disease management, where consistency of formulation matters for both efficacy and client compliance.

The staffing dimension compounds the supply problem. Burnout among veterinary professionals has been a documented concern across North America for several years, driven by long hours, high caseloads and the emotional weight of the work. When team members reduce hours or leave the profession, remaining staff absorb the additional load — a cycle that shortages can worsen, since sourcing alternatives and managing treatment changes takes staff time that clinics can ill afford.

The association's decision to speak publicly signals that these are no longer isolated clinic-level issues but national concerns warranting broader attention from regulators, suppliers and policymakers. Drug shortages in human medicine have prompted coordinated federal monitoring in Canada; veterinary supply chains have historically received less structured oversight, leaving associations like the CV A to fill the advocacy gap.

For clinic owners and practice managers, the warning is a prompt to review contingency plans: maintaining relationships with compounding pharmacies, documenting substitution protocols, cross-training staff to absorb absences, and tracking burnout indicators within their own teams before turnover forces the issue.

The Canadian Veterinary Association has not indicated that either problem shows near-term signs of resolution, and observers of the profession should expect continued pressure on both drug availability and workforce retention in the months ahead.